The risks and benefits of taking aspirin during pregnancy.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 2286215)

Published in Epidemiol Rev on January 01, 1990

Authors

I Hertz-Picciotto1, C Hopenhayn-Rich, M Golub, K Hooper

Author Affiliations

1: Department of Epidemiology, University of North Carolina, Chapel Hill 27599-7400.

Articles by these authors

Cancer risks from arsenic in drinking water. Environ Health Perspect (1992) 6.98

Arsenic ingestion and internal cancers: a review. Am J Epidemiol (1992) 4.39

The hazard evaluation system and information service: a physician's resource in toxicology and occupational medicine. West J Med (1982) 2.11

Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev (1994) 1.71

Health education, public policy and disease prevention: a case history of the New York City Coalition to End Lead Poisoning. Health Educ Q (1987) 1.70

Metabolism of prostaglandins A1 and E1 in man. J Clin Invest (1975) 1.50

Arsenic-laced water in Chile. Science (1998) 1.46

Review of the relation between blood lead and blood pressure. Epidemiol Rev (1993) 1.40

Residential indoor PM2.5 in wood stove homes: follow-up of the Libby changeout program. Indoor Air (2012) 1.40

Observations on the dose-response curve for arsenic exposure and lung cancer. Scand J Work Environ Health (1993) 1.34

Results of a residential indoor PM2.5 sampling program before and after a woodstove changeout. Indoor Air (2008) 1.33

Arsenic in drinking water and bladder cancer. Cancer Invest (2000) 1.32

Relationship of urinary arsenic to intake estimates and a biomarker of effect, bladder cell micronuclei. Mutat Res (1997) 1.31

Role of prostaglandins in the pathogenesis of Bartter's syndrome. Am J Med (1976) 1.27

Workshop on perinatal exposure to dioxin-like compounds. I. Summary. Environ Health Perspect (1995) 1.15

Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Cancer Epidemiol Biomarkers Prev (1997) 1.08

Reproductive and developmental toxicity of toluene: a review. Environ Health Perspect (1991) 1.06

Prioritizing candidate reproductive/developmental toxicants for evaluation. Reprod Toxicol (1992) 1.02

Effect of essential amino acids on mouse embryo viability and ammonium production. J Assist Reprod Genet (2001) 0.98

Decrease in bladder cell micronucleus prevalence after intervention to lower the concentration of arsenic in drinking water. Cancer Epidemiol Biomarkers Prev (1997) 0.98

Circadian activity associated with spatial learning and memory in aging rhesus monkeys. Exp Neurol (2009) 0.98

Fatty acid composition of low-density lipoprotein influences its susceptibility to autoxidation. Biochemistry (1994) 0.92

Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats. Am J Physiol (1990) 0.91

Ranking the carcinogenic hazards of occupational exposures: Exposure-Potency Index (EPI) values for nine volatile industrial chemicals. Prog Clin Biol Res (1986) 0.86

Human somatic mutation assays as biomarkers of carcinogenesis. Environ Health Perspect (1991) 0.86

Selective inhibition of angiotensin II-mediated vasoconstriction by lipoxygenase blockade. Am J Physiol (1989) 0.85

12-Lipoxygenase products modulate calcium signals in vascular smooth muscle cells. Hypertension (1992) 0.83

Arsenic risk assessment. Environ Health Perspect (1995) 0.83

Genetic toxicity of malathion: a review. Environ Mol Mutagen (1993) 0.83

The lipoxygenase inhibitor phenidone is a potent hypotensive agent in the spontaneously hypertensive rat. Am J Hypertens (1993) 0.82

A radioimmunoassay for prostaglandin A1 in human peripheral blood. J Clin Endocrinol Metab (1975) 0.81

Resolving discrepancies among studies: the influence of dose on effect size. Epidemiology (1994) 0.81

Congener-specific analysis of PCBs in human milk from Kazakhstan. Chemosphere (1998) 0.81

Comparing alternative approaches to establishing regulatory levels for reproductive toxicants: DBCP as a case study. Environ Health Perspect (1991) 0.80

Rationale for selecting exfoliated bladder cell micronuclei as potential biomarkers for arsenic genotoxicity. J Toxicol Environ Health (1993) 0.80

Tandem-in-time mass spectrometry method for the sub-parts-per-trillion determination of 2,3,7,8-chlorine-substituted dibenzo-p-dioxins and -furans in high-fat foods. Anal Chem (1999) 0.79

Tonic inhibition of renin secretion by the 12 lipoxygenase pathway: augmentation by high salt intake. Endocrinology (1996) 0.79

Bcl-2 antisense oligonucleotides enhance the cytotoxicity of chlorambucil in B-cell chronic lymphocytic leukaemia cells. Leuk Lymphoma (2001) 0.79

Effects of testing age and fostering experience on seizure susceptibility of rats treated prenatally with chlorpromazine. Dev Psychobiol (1975) 0.77

Stimulation of intestinal mucosal afferent nerves increases superior mesenteric artery and decreases mesenteric adipose tissue blood flow. Dig Dis Sci (2001) 0.76

Induction of renin release by exogenous prostaglandins in hyporeninemic hypoaldosteronism. Prostaglandins (1980) 0.76

Color correction in planar optics configurations. Opt Lett (2006) 0.75

The effect of angiotensin II and indomethacin on immunoreactive prostaglandin "A" levels in man. Prostaglandins (1976) 0.75

Carcinogens and regulation. Science (1981) 0.75

Epigenetic carcinogens: problems with identification and risk estimation. J Toxicol Clin Toxicol (1984) 0.75

Dopaminergic modulation of meal-stimulated and circadian secretion of pancreatic polypeptide in man. J Clin Endocrinol Metab (1983) 0.75

Reticular stimulation in the pregnant rat: effects on offspring. Physiol Behav (1977) 0.75

Hypotensive effects of the lipoxygenase inhibitor phenidone in two-kidney, one clip Goldblatt hypertension. Am J Hypertens (1989) 0.75

[Study of the anterior radiophotographic images in adult tuberculosis registers]. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol (1984) 0.75

[Ultrasound therapy in Meniere's disease]. Vestn Otorinolaringol (1966) 0.75

Modification of the behavioral response to drugs in rats exposed prenatally to chlorpromazine. Psychopharmacologia (1975) 0.75

Cyclooxygenase products and cyclic nucleotide levels with infusion of arachidonic acid, PGI2, PGE2, PGF2, and 6-keto-PGF1 in an isolated dog lung. Am Rev Respir Dis (1983) 0.75

Seizure susceptibility and avoidance conditioning in adult rats treated prenatally with chlorpromazine. Dev Psychobiol (1974) 0.75

Effect of high calcium intake on pressor responsivity in hypertensive rats. Am J Physiol (1987) 0.75

Role of prolactin and the renin-angiotensin system in mediating dopaminergic control of aldosterone secretion in the rat. Clin Exp Hypertens (1981) 0.75

[Clinical, radiological and bacteriological study of pulmonary tuberculosis with bacteria showing drug resistance]. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol (1978) 0.75